These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16971898)

  • 1. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.
    Barak S; Weiner I
    Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.
    Barak S; Weiner I
    Psychopharmacology (Berl); 2010 Apr; 209(2):175-84. PubMed ID: 20179909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1233-46. PubMed ID: 21211109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
    Weiner I; Schiller D; Gaisler-Salomon I
    Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women?
    Arad M; Weiner I
    Psychoneuroendocrinology; 2008 Nov; 33(10):1401-10. PubMed ID: 18819755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
    Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
    Zuckerman L; Rimmerman N; Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):298-307. PubMed ID: 12827344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.
    Weiner I; Arad M
    Behav Brain Res; 2009 Dec; 204(2):369-86. PubMed ID: 19433114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.
    Schiller D; Zuckerman L; Weiner I
    J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
    Arad M; Weiner I
    Neuropsychopharmacology; 2010 Jun; 35(7):1570-82. PubMed ID: 20237462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli.
    Barak S; Weiner I
    Neuropsychopharmacology; 2010 Apr; 35(5):1073-82. PubMed ID: 20072122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.
    Shadach E; Gaisler I; Schiller D; Weiner I
    Neuropsychopharmacology; 2000 Aug; 23(2):151-61. PubMed ID: 10882841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
    Zuckerman L; Rehavi M; Nachman R; Weiner I
    Neuropsychopharmacology; 2003 Oct; 28(10):1778-89. PubMed ID: 12865897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.
    Barak S; Arad M; De Levie A; Black MD; Griebel G; Weiner I
    Neuropsychopharmacology; 2009 Jun; 34(7):1753-63. PubMed ID: 19158670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.
    Arad M; Weiner I
    Psychoneuroendocrinology; 2012 Feb; 37(2):200-12. PubMed ID: 21723667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.
    McDonald LM; Moran PM; Vythelingum GN; Joseph MH; Stephenson JD; Gray JA
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):321-31. PubMed ID: 14530903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.